Vishakha Sabharwal

Vishakha Sabharwal

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Placenta
Verified
Journal Article
Closed access
ETElizabeth Taglauer
Elizabeth Taglauer
YBYoel Benarroch
Yoel Benarroch
KRKevin Rop
Kevin Rop
EBElizabeth Barnett
Elizabeth Barnett
VSVishakha Sabharwal
Vishakha Sabharwal
EWElisha M Wachman
Elisha M Wachman

1 May 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LQLee J. Quinton
Lee J. Quinton
MBMatthew T. Blahna
Matthew T. Blahna
MJMatthew R. Jones
Matthew R. Jones
EAEri Allen
Eri Allen
JFJoseph D. Ferrari
Joseph D. Ferrari
JMJoseph P. Mizgerd
Joseph P. Mizgerd
The acute phase response is an evolutionarily conserved reaction in which physiological stress triggers the liver to remodel the blood proteome. Although thought to be involved in immune defense, the net biological effect of the acute phase response remains unknown. As the acute phase response is stimulated by diverse cytokines that activate either NF-κB or STAT3, we hypothesized that it could be eliminated by hepatocyte-specific interruption of both transcription factors. Here, we report that the elimination in mice of both NF-κB p65 (RelA) and STAT3, but neither alone, abrogated all acute phase responses measured. The failure to respond was consistent across multiple different infectious, inflammatory, and noxious stimuli, including pneumococcal pneumonia. When the effects of infection were analyzed in detail, pneumococcal pneumonia was found to alter the expression of over a thousand transcripts in the liver. This outcome was inhibited by the combined loss of RelA and STAT3. Moreover, this interruption of the acute phase response increased mortality and exacerbated bacterial dissemination during pneumonia, possibly as a result of acute humoral enhancement of macrophage opsonophagocytosis, which was impaired in the mutant mice. Thus, we conclude that RelA and STAT3 are essential for stress-induced transcriptional remodeling in the liver and the subsequent activation of the acute phase response, whose functional role includes compartmentalization of local infection.

1 January 2013 in Biomaterials
Verified
Journal Article
Closed access
XKXiaojuan Khoo
Xiaojuan Khoo
ESEmmanuel J. Simons
Emmanuel J. Simons
HCHomer H. Chiang
Homer H. Chiang
JHJulia M. Hickey
Julia M. Hickey
VSVishakha Sabharwal
Vishakha Sabharwal
DKDaniel S. Kohane
Daniel S. Kohane

4 October 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
RYRong Yang
Rong Yang
VSVishakha Sabharwal
Vishakha Sabharwal
NSNadya Shlykova
Nadya Shlykova
OOObiajulu S. Okonkwo
Obiajulu S. Okonkwo
SPStephen I. Pelton
Stephen I. Pelton
DKDaniel S. Kohane
Daniel S. Kohane
Otits media (OM) is the most frequent indication for antimicrobial prescription to US children. Streptococcus pneumoniae ( S . pneumoniae ) remains one of the most common pathogens causing OM. Successful eradication of S . pneumoniae in the middle ear can be achieved by adhering to a 7–10 day regimen of oral antibiotics. However, oral drug administration is challenging for parents. Lack of adherence has been associated with treatment failure or early relapse. To overcome this challenge, we used a noninvasive formulation to achieve high transtympanic antibiotic flux and cured S . pneumoniae OM in chinchillas. The formulation consists of a thermosensitive in situ gelling hydrogel, chemical permeation enhancers, and an antibiotic. The direct transport of drugs into the middle ear produced high concentrations of ciprofloxacin (in the range of hundreds of micrograms per milliliter) within the first 24 hours of administration. Drug concentrations above the minimum inhibitory concentration (MIC) for S . pneumoniae were sustained throughout the 7-day treatment. S . pneumoniae OM in a chinchilla model was successfully eradicated, without causing tissue toxicity. Transtympanic delivery minimized systemic drug exposure, as evidenced by undetectable levels in blood, measured by high-performance liquid chromatography.

1 March 2009 in Infection and Immunity
Verified
Journal Article
Closed access
VSVishakha Sabharwal
Vishakha Sabharwal
SRSanjay Ram
Sanjay Ram
MFMarisol Figueira
Marisol Figueira
IPIn Ho Park
In Ho Park
SPStephen I I Pelton
Stephen I I Pelton
Strategies to limit complement deposition onStreptococcus pneumoniaeare established as virulence features for invasive disease, but their role in respiratory tract infection requires further analysis. We evaluated complement C3 protein deposition on discordantS. pneumoniaeisolates of the same serotype (6A) and their capacity to cause nasopharyngeal (NP) colonization and experimental otitis media (EOM) in an animal model. We compared C3 binding to five 6A isolates from asymptomatic NP carriers with five 6A strains that caused invasive disease, and we observed less C3 (∼10-fold less fluorescence) binding to invasive isolates. We selected two high-level C3-binding carriage and two low-level C3-binding invasive 6A isolates for further study. In the EOM model, 11/12 (92%) ears challenged with a low-level C3-binding 6A strain became infected. Only 2/8 (25%) ears challenged with the discordant high-level C3-binding 6A isolate developed disease (P= 0.005). Results with the second discordant 6A isolate pair were comparable. Cobra venom factor (CoVF) treatment, which depletes C3 and consumes complement, restored virulence of the high-level C3-binding strain; 8/8 (100%) ears in CoVF-treated animals developed EOM compared to only 25% of ears in naïve animals (P= 0.007). These studies demonstrate the critical role for complement evasion in pneumococcal EOM. Colonization with carriage isolates that bound high levels of C3 caused EOM in fewer animals compared to low-level C3-binding invasive strains. Thus, limiting C3 deposition on the surface ofS. pneumoniaecorrelates with increased incidence of EOM following NP colonization and barotrauma in the animal model.

1 February 2011 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
QXQingfu Xu
Qingfu Xu
RKRavinder Kaur
Ravinder Kaur
JCJanet R. Casey
Janet R. Casey
VSVishakha Sabharwal
Vishakha Sabharwal
SPStephen I I Pelton
Stephen I I Pelton
MPMichael E. Pichichero
Michael E. Pichichero